Berenberg lowers target price on Judges Scientific.


Analysts at Berenberg lowered their target price on scientific instruments business Judges Scientific from 12,400.0p to 11,310.0p on Tuesday, stating the group was approaching a "trough cycle".

Judges Scientific

Source: Sharecast

Earlier in the week, Judges Scientific published a trading update that H2 revealed orders that it was relying on to meet market expectations would no longer be delivered in time.

However, Berenberg stated that in the context of "well-flagged, persistent end-market weaknesses", Judges' profit warning, while disappointing, was perhaps unsurprising.

"Given the magnitude of the guidance revision, we think that this may be the last 'cut' in a tough cycle for Judges," said Berenberg.

But the German bank also noted that a number of orders that have slipped in H224 should be delivered in FY25, including a highly profitable Geotek coring contract, and pointed out that Judges will begin to lap a soft comparable period, which should again trigger positive year-on-year growth.

"When the dust settles we therefore think an attractive buying opportunity may present itself," added Berenberg, which reiterated its 'buy' rating on the stock.

Reporting by Iain Gilbert at Sharecast.com


ISIN: GB0032398678
Exchange: London Stock Exchange
Sell:
7,800.00 p
Buy:
8,300.00 p
Change: 100.00 ( 1.27 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.